Understanding the TRANSFORM-HF Trial: BAPA Members for Summer Convention Only

August 20, 2023

Target Audience

All pharmacists

Learning Objectives

At the completion of this activity, the participant will be able to:

Identify the risk factors and symptoms of Heart Failure
Understand the differences between Furosemide and Torsemide as per the TRANSFORM-HF trial
Recognize the treatments and understand current treatment guidelines for Heart Failure
State the difference between treatment options for heart Failure particularly between Torsemide and
Furosemide

Course summary

Available credit: 
  • 2.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Course opens: 
08/16/2023
Course expires: 
11/21/2025
Event starts: 
08/20/2023 - 9:00am EDT
Event ends: 
08/20/2023 - 11:00am EDT
Cost:
$0.00
Add to calendar: 
Rating: 
0
Hilton Philadelphia at Penn's Landing
201 S Christopher Columbus Blvd.
Philadelphia, PA
United States

Rafi Reyasat- Regional Medical Director- Urologic Oncology- Merck Rafi Reyasat is a Regional Medical Director for Urologic Oncology at Merck. Rafi completed his PharmD at St. John’s University and went on to complete his Post-Doctoral fellowship in GU Oncology Medical Affairs with Rutgers University and Pfizer. Rafi has worked in the GU oncology space for 5 years in roles of increasing responsibility at Pfizer and Merck

ACPE UAN #  0042-9999-23-073-L01-P

Available Credit

  • 2.00 ACPE
    The Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Price

Cost:
$0.00
Please login or register to take this course.